Completed
Compounded topical pain creams have gained popularity among some prescribers and patients, as they are marketed as having fewer side effects, lower likelihood for abuse, and the potential for greater efficacy and convenience than certain oral pain medications. Importantly, the FDA does not review or approve the safety and effectiveness of compounded preparations. Many ingredients used in compounded topical pain creams are not FDA-approved to treat pain, and many contain multiple active ingredients, prompting the FDA to ask the National Academies to convene a consensus study to evaluate the safety and effectiveness of the ingredients used in these compounded preparations.
Events
Report Release Webinar: Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- May 13, 2020
- 11:00 AM - 3:30 PM (ET)
- Workshop
- Past
The National Academies of Sciences, Engineering, and Medicine Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topi...
Fifth Meeting of the Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- February 25, 2020
- 10:00 AM - 1:00 PM (ET)
- Closed
- Meeting
- Past
Closed Session to discuss Report Review.
Fourth Meeting of the Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- September 30 - October 1, 2019
- Meeting
- Past
The National Academies of Sciences, Engineering, and Medicine is pleased to announce the Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredie...
Third Meeting of the Committee on Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- July 30 - 31, 2019
- Closed
- Past
The National Academies of Sciences, Engineering, and Medicine is holding a closed session meeting for the Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiv...
Second Meeting of the Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- May 20 - 22, 2019
- Meeting
- Past
The National Academies of Sciences, Engineering, and Medicine is pleased to announce the second open session meeting for the Committee on the Assessment of the Available Scientific Data Regarding the...
Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- April 24, 2019
- 4:00 PM - 5:30 PM (ET)
- Closed
- Tele Conference
- Past
Discussion to plan the agenda for the second committee meeting.
First meeting of the Committee on the Assessment of the Available Scientific Data Regarding the Safety and Effectiveness of Ingredients Used in Compounded Topical Pain Creams
- March 25 - 26, 2019
- Meeting
- Past
The National Academies of Sciences, Engineering, and Medicine is pleased to announce the first open session meeting for the Committee on the Assessment of the Available Scientific Data Regarding the S...